Home › Funds › Velan Capital Investment Management LP › QNRX

Velan Capital Investment Management LP position in QNRX

QUOIN PHARMACEUTICALS LTD · Health Care

Velan Capital Investment Management LP reported holding 32,372 shares of QNRX (QUOIN PHARMACEUTICALS LTD) in its Q2 2026 13F filing — a position valued at US$157K, representing 0.10% of its reported portfolio and ranking #43 among its reported holdings. Velan Capital Investment Management LP has disclosed QNRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)32.37K sh
Reported value held$156.68K
Portfolio Weight0.10%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's QNRX position evolved

Velan Capital Investment Management LP first disclosed a stake in QNRX in Q1 2026 at 84,849 shares (US$560K). Across 2 filings, Velan Capital Investment Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 32,372 shares valued at US$157K — a reduction of -52,477 shares quarter over quarter.. Notable position changes include a 62% trim in Q2 2026 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 84.85K $560.00K New
Q2 2026 32.37K $156.68K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QNRX and 13F data

QNRX (QUOIN PHARMACEUTICALS LTD) is a Health Care company. 20 other funds we track also report a position in QNRX — the largest reported positions include Dauntless Investment Group, LLC (US$1.0M), Stonepine Capital Management, LLC (US$966K), AIGH Capital Management LLC (US$339K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QNRX

All QNRX fund holders →

FAQ

How long has Velan Capital Investment Management LP held QNRX?

Velan Capital Investment Management LP has disclosed QNRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Velan Capital Investment Management LP's current position in QNRX?

As of Q2 2026, Velan Capital Investment Management LP holds 32.37K shares of QNRX (QUOIN PHARMACEUTICALS LTD), valued at $156.68K, representing 0.10% of its reported portfolio and ranking #43.

Has Velan Capital Investment Management LP been buying or selling QNRX?

In the latest 13F filing (Q2 2026), Velan Capital Investment Management LP reduced its position in QNRX.

Which other funds hold QNRX?

Other major institutional holders of QNRX include Dauntless Investment Group, LLC, Stonepine Capital Management, LLC, AIGH Capital Management LLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.